Pavan Cheruvu

No open positions remaining

Net worth: 2 M $ as of 31/05/2026

45 year

Consumer Services

Health Technology

Profile

Pavan K.
Cheruvu is currently Chief Executive Officer & Director at Amanat Acquisition Corp.
Former positions include Chief Executive Officer at Sio Gene Therapies, Inc. from 2018 to 2018, Chief Executive Officer at Axovant Sciences, Inc. from 2018 to 2020, and President, Chief Executive Officer & Director at Bitterroot Bio, Inc. Education includes undergraduate studies at Duke University, graduate studies at the University of Oxford, and a doctorate from Harvard Medical School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
6.9%	19/05/2026	1,50,000 ( 6.9% )	2 M $	31/05/2026

Pavan Cheruvu active positions

Companies	Position	Start

All active positions of Pavan Cheruvu

Former positions of Pavan Cheruvu

Companies	Position	End
Bitterroot Bio, Inc. Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases	Chief Executive Officer	01/02/2026
SIO GENE THERAPIES INC.	Chief Executive Officer	31/01/2022
Axovant Sciences, Inc. Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Chief Executive Officer	01/12/2020

See the detail of Pavan Cheruvu's experience

Training of Pavan Cheruvu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pavan Cheruvu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Duke University Duke University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sio Gene Therapies, Inc. Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases	Health Technology
Axovant Sciences, Inc. Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Bitterroot Bio, Inc. Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases	Health Technology